COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abbott Laboratories | Common | 002824100 | 40,221 | 369,573 | SH | | SOLE | | 369,573 | 0 | 0 |
AbbVie Inc. | Common | 00287Y109 | 76,617 | 874,720 | SH | | SOLE | | 874,720 | 0 | 0 |
ABIOMED, Inc. | Common | 003654100 | 3,383 | 12,212 | SH | | SOLE | | 12,212 | 0 | 0 |
AC Immune SA | Shares | H00263105 | 838 | 171,813 | SH | | SOLE | | 171,813 | 0 | 0 |
Acadia Healthcare Co., Inc. | Common | 00404A109 | 3,868 | 131,200 | SH | | SOLE | | 131,200 | 0 | 0 |
ACADIA Pharmaceuticals Inc. | Common | 004225108 | 10,343 | 250,743 | SH | | SOLE | | 250,743 | 0 | 0 |
Adaptive Biotechnologies Corp. | Common | 00650F109 | 1,202 | 24,715 | SH | | SOLE | | 24,715 | 0 | 0 |
Addus HomeCare Corp. | Common | 006739106 | 1,509 | 15,969 | SH | | SOLE | | 15,969 | 0 | 0 |
Aerie Pharmaceuticals, Inc. | Common | 00771V108 | 785 | 66,688 | SH | | SOLE | | 66,688 | 0 | 0 |
Agilent Technologies, Inc. | Common | 00846U101 | 5,302 | 52,525 | SH | | SOLE | | 52,525 | 0 | 0 |
Agios Pharmaceuticals, Inc. | Common | 00847X104 | 6,544 | 186,964 | SH | | SOLE | | 186,964 | 0 | 0 |
Alcon Inc. | Ordinary Shares | H01301128 | 2,089 | 36,686 | SH | | SOLE | | 36,686 | 0 | 0 |
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 30,529 | 266,791 | SH | | SOLE | | 266,791 | 0 | 0 |
Align Technology, Inc. | Common | 016255101 | 3,287 | 10,041 | SH | | SOLE | | 10,041 | 0 | 0 |
Alkermes plc | Shares | G01767105 | 2,816 | 169,930 | SH | | SOLE | | 169,930 | 0 | 0 |
Allakos Inc. | Common | 01671P100 | 5,245 | 64,397 | SH | | SOLE | | 64,397 | 0 | 0 |
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 25,465 | 174,894 | SH | | SOLE | | 174,894 | 0 | 0 |
Amarin Corp. plc | Sponsored ADR | 023111206 | 3,577 | 849,588 | SH | | SOLE | | 849,588 | 0 | 0 |
Amedisys, Inc. | Common | 023436108 | 4,586 | 19,395 | SH | | SOLE | | 19,395 | 0 | 0 |
AmerisourceBergen Corp. | Common | 03073E105 | 7,816 | 80,645 | SH | | SOLE | | 80,645 | 0 | 0 |
Amgen Inc. | Common | 031162100 | 154,585 | 608,218 | SH | | SOLE | | 608,218 | 0 | 0 |
Amicus Therapeutics, Inc. | Common | 03152W109 | 5,727 | 405,626 | SH | | SOLE | | 405,626 | 0 | 0 |
Anthem, Inc. | Common | 036752103 | 9,974 | 37,133 | SH | | SOLE | | 37,133 | 0 | 0 |
Apellis Pharmaceuticals, Inc. | Common | 03753U106 | 6,517 | 216,017 | SH | | SOLE | | 216,017 | 0 | 0 |
ARCA biopharma, Inc. | Common | 00211Y506 | 143 | 32,461 | SH | | SOLE | | 32,461 | 0 | 0 |
Ardelyx, Inc. | Common | 039697107 | 3,190 | 607,698 | SH | | SOLE | | 607,698 | 0 | 0 |
Arena Pharmaceuticals, Inc. | Common | 040047607 | 12,014 | 160,637 | SH | | SOLE | | 160,637 | 0 | 0 |
argenx SE | Sponsored ADR | 04016X101 | 16,194 | 61,687 | SH | | SOLE | | 61,687 | 0 | 0 |
Arrowhead Pharmaceuticals, Inc. | Common | 04280A100 | 3,194 | 74,186 | SH | | SOLE | | 74,186 | 0 | 0 |
Ascendis Pharma A/S | Sponsored ADR | 04351P101 | 19,405 | 125,746 | SH | | SOLE | | 125,746 | 0 | 0 |
Assertio Holdings, Inc. | Common | 04546C106 | 1,093 | 1,642,302 | SH | | SOLE | | 1,642,302 | 0 | 0 |
AstraZeneca PLC | Sponsored ADR | 046353108 | 18,869 | 344,333 | SH | | SOLE | | 344,333 | 0 | 0 |
Atreca, Inc. | Class A Common | 04965G109 | 4,923 | 352,424 | SH | | SOLE | | 352,424 | 0 | 0 |
Aurinia Pharmaceuticals Inc. | Common | 05156V102 | 4,428 | 300,611 | SH | | SOLE | | 300,611 | 0 | 0 |
Avadel Pharmaceuticals plc | Sponsored ADR | 05337M104 | 1,177 | 233,612 | SH | | SOLE | | 233,612 | 0 | 0 |
Axonics Modulation Technologies, Inc. | Common | 05465P101 | 990 | 19,400 | SH | | SOLE | | 19,400 | 0 | 0 |
Axsome Therapeutics, Inc. | Common | 05464T104 | 2,251 | 31,591 | SH | | SOLE | | 31,591 | 0 | 0 |
Bausch Health Companies Inc. | Common | 071734107 | 1,840 | 118,412 | SH | | SOLE | | 118,412 | 0 | 0 |
Baxter International Inc. | Common | 071813109 | 9,813 | 122,023 | SH | | SOLE | | 122,023 | 0 | 0 |
Becton, Dickinson and Co. | Common | 075887109 | 30,649 | 131,723 | SH | | SOLE | | 131,723 | 0 | 0 |
BeiGene, Ltd. | Sponsored ADR | 07725L102 | 8,101 | 28,280 | SH | | SOLE | | 28,280 | 0 | 0 |
Bellicum Pharmaceuticals, Inc. | Common | 079481404 | 39 | 6,000 | SH | | SOLE | | 6,000 | 0 | 0 |
Bio-Techne Corp. | Common | 09073M104 | 12,810 | 51,710 | SH | | SOLE | | 51,710 | 0 | 0 |
Biogen Inc. | Common | 09062X103 | 60,637 | 213,753 | SH | | SOLE | | 213,753 | 0 | 0 |
Biohaven Pharmaceutical Holding Co. Ltd. | Common | G11196105 | 2,228 | 34,277 | SH | | SOLE | | 34,277 | 0 | 0 |
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 24,789 | 325,822 | SH | | SOLE | | 325,822 | 0 | 0 |
BioNTech SE | Sponsored ADS | 09075V102 | 3,018 | 43,595 | SH | | SOLE | | 43,595 | 0 | 0 |
bluebird bio, Inc. | Common | 09609G100 | 4,542 | 84,194 | SH | | SOLE | | 84,194 | 0 | 0 |
Blueprint Medicines Corp. | Common | 09627Y109 | 15,761 | 170,018 | SH | | SOLE | | 170,018 | 0 | 0 |
Boston Scientific Corp. | Common | 101137107 | 28,325 | 741,296 | SH | | SOLE | | 741,296 | 0 | 0 |
Bristol Myers Squibb Co. | Common | 110122108 | 56,982 | 945,140 | SH | | SOLE | | 945,140 | 0 | 0 |
Bristol Myers Squibb Co. | Right | 110122157 | 3,316 | 1,473,710 | SH | | SOLE | | 1,473,710 | 0 | 0 |
Celldex Therapeutics, Inc. | Common | 15117B202 | 105 | 7,053 | SH | | SOLE | | 7,053 | 0 | 0 |
Cellectis S.A. | Sponsored ADR | 15117K103 | 2,038 | 110,147 | SH | | SOLE | | 110,147 | 0 | 0 |
Centene Corp. | Common | 15135B101 | 26,733 | 458,313 | SH | | SOLE | | 458,313 | 0 | 0 |
Cerner Corp. | Common | 156782104 | 5,892 | 81,500 | SH | | SOLE | | 81,500 | 0 | 0 |
Charles River Laboratories International, Inc. | Common | 159864107 | 6,964 | 30,754 | SH | | SOLE | | 30,754 | 0 | 0 |
ChemoCentryx, Inc. | Common | 16383L106 | 7,916 | 144,447 | SH | | SOLE | | 144,447 | 0 | 0 |
Cigna Corp. | Common | 125523100 | 12,069 | 71,241 | SH | | SOLE | | 71,241 | 0 | 0 |
Clearside Biomedical, Inc. | Common | 185063104 | 255 | 165,330 | SH | | SOLE | | 165,330 | 0 | 0 |
Cogent Biosciences, Inc. | Common | 19240Q102 | 2,581 | 1,103,175 | SH | | SOLE | | 1,103,175 | 0 | 0 |
Coherus Biosciences, Inc. | Common | 19249H103 | 3,725 | 203,103 | SH | | SOLE | | 203,103 | 0 | 0 |
Community Health Systems, Inc. | Common | 203668108 | 497 | 117,735 | SH | | SOLE | | 117,735 | 0 | 0 |
Community Healthcare Trust Inc. | Common | 20369C106 | 697 | 14,900 | SH | | SOLE | | 14,900 | 0 | 0 |
Corbus Pharmaceuticals Holdings, Inc. | Common | 21833P103 | 744 | 413,481 | SH | | SOLE | | 413,481 | 0 | 0 |
CRISPR Therapeutics AG | Namen AKT | H17182108 | 6,375 | 76,222 | SH | | SOLE | | 76,222 | 0 | 0 |
CVS Health Corp. | Common | 126650100 | 22,675 | 388,263 | SH | | SOLE | | 388,263 | 0 | 0 |
CymaBay Therapeutics, Inc. | Common | 23257D103 | 638 | 88,102 | SH | | SOLE | | 88,102 | 0 | 0 |
Danaher Corp. | Common | 235851102 | 14,549 | 67,567 | SH | | SOLE | | 67,567 | 0 | 0 |
Deciphera Pharmaceuticals, Inc. | Common | 24344T101 | 3,148 | 61,370 | SH | | SOLE | | 61,370 | 0 | 0 |
DENTSPLY SIRONA Inc. | Common | 24906P109 | 17,863 | 408,473 | SH | | SOLE | | 408,473 | 0 | 0 |
DexCom, Inc. | Common | 252131107 | 7,644 | 18,544 | SH | | SOLE | | 18,544 | 0 | 0 |
Dicerna Pharmaceuticals, Inc. | Common | 253031108 | 1,226 | 68,150 | SH | | SOLE | | 68,150 | 0 | 0 |
Diversified Healthcare Trust | Common | 25525P107 | 1,259 | 357,720 | SH | | SOLE | | 357,720 | 0 | 0 |
Edwards Lifesciences Corp. | Common | 28176E108 | 23,240 | 291,155 | SH | | SOLE | | 291,155 | 0 | 0 |
Eidos Therapeutics, Inc. | Common | 28249H104 | 1,011 | 20,000 | SH | | SOLE | | 20,000 | 0 | 0 |
Eli Lilly and Co. | Common | 532457108 | 26,294 | 177,637 | SH | | SOLE | | 177,637 | 0 | 0 |
Endo International plc | Shares | G30401106 | 1,754 | 531,570 | SH | | SOLE | | 531,570 | 0 | 0 |
Esperion Therapeutics, Inc. | Common | 29664W105 | 1,545 | 41,577 | SH | | SOLE | | 41,577 | 0 | 0 |
Exact Sciences Corp. | Common | 30063P105 | 1,545 | 15,150 | SH | | SOLE | | 15,150 | 0 | 0 |
Exelixis, Inc. | Common | 30161Q104 | 26,776 | 1,095,117 | SH | | SOLE | | 1,095,117 | 0 | 0 |
Fate Therapeutics, Inc. | Common | 31189P102 | 8,692 | 217,462 | SH | | SOLE | | 217,462 | 0 | 0 |
FibroGen, Inc. | Common | 31572Q808 | 7,988 | 194,270 | SH | | SOLE | | 194,270 | 0 | 0 |
Five Star Senior Living Inc. | Common | 33832D205 | 123 | 24,237 | SH | | SOLE | | 24,237 | 0 | 0 |
Galapagos NV | Sponsored ADR | 36315X101 | 929 | 6,543 | SH | | SOLE | | 6,543 | 0 | 0 |
Galera Therapeutics, Inc. | Common | 36338D108 | 9,418 | 1,041,845 | SH | | SOLE | | 1,041,845 | 0 | 0 |
Genmab A/S | Sponsored ADS | 372303206 | 6,765 | 184,779 | SH | | SOLE | | 184,779 | 0 | 0 |
Gilead Sciences, Inc. | Common | 375558103 | 103,864 | 1,643,683 | SH | | SOLE | | 1,643,683 | 0 | 0 |
GlaxoSmithKline PLC | Shares | 37733W105 | 1,220 | 32,400 | SH | | SOLE | | 32,400 | 0 | 0 |
Global Blood Therapeutics, Inc. | Common | 37890U108 | 3,957 | 71,759 | SH | | SOLE | | 71,759 | 0 | 0 |
Global Medical REIT Inc. | Common | 37954A204 | 2,361 | 174,897 | SH | | SOLE | | 174,897 | 0 | 0 |
Grifols, S.A. | Sponsored ADR | 398438408 | 822 | 47,373 | SH | | SOLE | | 47,373 | 0 | 0 |
Guardant Health, Inc. | Common | 40131M109 | 13,173 | 117,852 | SH | | SOLE | | 117,852 | 0 | 0 |
Harpoon Therapeutics, Inc. | Common | 41358P106 | 1,808 | 106,419 | SH | | SOLE | | 106,419 | 0 | 0 |
HCA Healthcare, Inc. | Common | 40412C101 | 10,215 | 81,933 | SH | | SOLE | | 81,933 | 0 | 0 |
Health Care Select Sector SPDR Fund | SBI Healthcare | 81369Y209 | 1,061 | 10,055 | SH | | SOLE | | 10,055 | 0 | 0 |
Healthcare Realty Trust Inc. | Common | 421946104 | 3,133 | 104,024 | SH | | SOLE | | 104,024 | 0 | 0 |
Healthcare Trust of America, Inc. | Common | 42225P501 | 1,837 | 70,662 | SH | | SOLE | | 70,662 | 0 | 0 |
Healthpeak Properties, Inc. | Common | 42250P103 | 4,083 | 150,392 | SH | | SOLE | | 150,392 | 0 | 0 |
Heron Therapeutics, Inc. | Common | 427746102 | 1,944 | 131,183 | SH | | SOLE | | 131,183 | 0 | 0 |
Hologic, Inc. | Common | 436440101 | 2,165 | 32,564 | SH | | SOLE | | 32,564 | 0 | 0 |
Horizon Therapeutics plc | Shares | G46188101 | 46,894 | 603,684 | SH | | SOLE | | 603,684 | 0 | 0 |
Humana Inc. | Common | 444859102 | 35,597 | 86,007 | SH | | SOLE | | 86,007 | 0 | 0 |
IDEXX Laboratories, Inc. | Common | 45168D104 | 13,686 | 34,814 | SH | | SOLE | | 34,814 | 0 | 0 |
Illumina, Inc. | Common | 452327109 | 86,868 | 281,054 | SH | | SOLE | | 281,054 | 0 | 0 |
ImmunoGen, Inc. | Common | 45253H101 | 605 | 168,190 | SH | | SOLE | | 168,190 | 0 | 0 |
Immunomedics, Inc. | Common | 452907108 | 18,990 | 223,336 | SH | | SOLE | | 223,336 | 0 | 0 |
Incyte Corp. | Common | 45337C102 | 13,695 | 152,605 | SH | | SOLE | | 152,605 | 0 | 0 |
Inogen, Inc. | Common | 45780L104 | 1,491 | 51,406 | SH | | SOLE | | 51,406 | 0 | 0 |
Insmed Inc. | Common | 457669307 | 3,162 | 98,387 | SH | | SOLE | | 98,387 | 0 | 0 |
Intercept Pharmaceuticals, Inc. | Common | 45845P108 | 3,195 | 77,067 | SH | | SOLE | | 77,067 | 0 | 0 |
Intra-Cellular Therapies, Inc. | Common | 46116X101 | 2,418 | 94,238 | SH | | SOLE | | 94,238 | 0 | 0 |
Intuitive Surgical, Inc. | Common | 46120E602 | 17,787 | 25,069 | SH | | SOLE | | 25,069 | 0 | 0 |
Ionis Pharmaceuticals, Inc. | Common | 462222100 | 9,167 | 193,201 | SH | | SOLE | | 193,201 | 0 | 0 |
Iovance Biotherapeutics, Inc. | Common | 462260100 | 8,924 | 271,073 | SH | | SOLE | | 271,073 | 0 | 0 |
IQVIA Holdings Inc. | Common | 46266C105 | 12,968 | 82,266 | SH | | SOLE | | 82,266 | 0 | 0 |
Jazz Pharmaceuticals plc | Shares | G50871105 | 9,619 | 67,456 | SH | | SOLE | | 67,456 | 0 | 0 |
Johnson & Johnson | Common | 478160104 | 81,408 | 546,805 | SH | | SOLE | | 546,805 | 0 | 0 |
Kadmon Holdings, Inc. | Common | 48283N106 | 2,799 | 714,008 | SH | | SOLE | | 714,008 | 0 | 0 |
Karuna Therapeutics, Inc. | Common | 48576A100 | 3,234 | 41,827 | SH | | SOLE | | 41,827 | 0 | 0 |
Karyopharm Therapeutics Inc. | Common | 48576U106 | 960 | 65,743 | SH | | SOLE | | 65,743 | 0 | 0 |
Koninklijke Philips N.V. | NY Reg Sh | 500472303 | 2,684 | 56,927 | SH | | SOLE | | 56,927 | 0 | 0 |
Kura Oncology, Inc. | Common | 50127T109 | 1,818 | 59,339 | SH | | SOLE | | 59,339 | 0 | 0 |
Laboratory Corporation of America Holdings | Sponsored ADR | 50540R409 | 13,179 | 70,003 | SH | | SOLE | | 70,003 | 0 | 0 |
LTC Properties, Inc. | Common | 502175102 | 6,355 | 182,293 | SH | | SOLE | | 182,293 | 0 | 0 |
Madrigal Pharmaceuticals, Inc. | Common | 558868105 | 1,584 | 13,340 | SH | | SOLE | | 13,340 | 0 | 0 |
Magenta Therapeutics, Inc. | Common | 55910K108 | 1,309 | 192,431 | SH | | SOLE | | 192,431 | 0 | 0 |
Mallinckrodt plc | Sponsored ADR | G5785G107 | 32 | 32,980 | SH | | SOLE | | 32,980 | 0 | 0 |
McKesson Corp. | Common | 58155Q103 | 16,015 | 107,537 | SH | | SOLE | | 107,537 | 0 | 0 |
Medical Properties Trust, Inc. | Common | 58463J304 | 7,259 | 411,743 | SH | | SOLE | | 411,743 | 0 | 0 |
Medpace Holdings, Inc. | Common | 58506Q109 | 2,109 | 18,871 | SH | | SOLE | | 18,871 | 0 | 0 |
Medtronic plc | Shares | G5960L103 | 55,588 | 534,914 | SH | | SOLE | | 534,914 | 0 | 0 |
Merck & Co., Inc. | Common | 58933Y105 | 87,654 | 1,056,706 | SH | | SOLE | | 1,056,706 | 0 | 0 |
Mettler-Toledo International Inc. | Common | 592688105 | 9,464 | 9,800 | SH | | SOLE | | 9,800 | 0 | 0 |
Milestone Pharmaceuticals Inc. | Common | 59935V107 | 1,561 | 213,310 | SH | | SOLE | | 213,310 | 0 | 0 |
Mirati Therapeutics, Inc. | Common | 60468T105 | 13,082 | 78,784 | SH | | SOLE | | 78,784 | 0 | 0 |
Moderna, Inc. | Common | 60770K107 | 32,570 | 460,359 | SH | | SOLE | | 460,359 | 0 | 0 |
Molecular Templates, Inc. | Common | 608550109 | 2,400 | 219,822 | SH | | SOLE | | 219,822 | 0 | 0 |
Molina Healthcare, Inc. | Common | 60855R100 | 7,810 | 42,669 | SH | | SOLE | | 42,669 | 0 | 0 |
MorphoSys AG | Sponsored ADS | 617760202 | 2,570 | 81,867 | SH | | SOLE | | 81,867 | 0 | 0 |
Mylan N.V. | Shares | N59465109 | 14,989 | 1,010,754 | SH | | SOLE | | 1,010,754 | 0 | 0 |
MyoKardia, Inc. | Common | 62857M105 | 2,631 | 19,300 | SH | | SOLE | | 19,300 | 0 | 0 |
National Health Investors, Inc. | Common | 63633D104 | 605 | 10,038 | SH | | SOLE | | 10,038 | 0 | 0 |
Nektar Therapeutics | Common | 640268108 | 4,364 | 263,079 | SH | | SOLE | | 263,079 | 0 | 0 |
Neurocrine Biosciences, Inc. | Common | 64125C109 | 6,078 | 63,203 | SH | | SOLE | | 63,203 | 0 | 0 |
New Senior Investment Group Inc. | Common | 648691103 | 1,026 | 256,398 | SH | | SOLE | | 256,398 | 0 | 0 |
Novartis AG | Sponsored ADR | 66987V109 | 13,177 | 151,525 | SH | | SOLE | | 151,525 | 0 | 0 |
Novavax, Inc. | Common | 670002401 | 1,249 | 11,523 | SH | | SOLE | | 11,523 | 0 | 0 |
Novo Nordisk A/S | Sponsored ADR | 670100205 | 9,304 | 134,005 | SH | | SOLE | | 134,005 | 0 | 0 |
NovoCure Ltd. | Ordinary Shares | G6674U108 | 13,006 | 116,845 | SH | | SOLE | | 116,845 | 0 | 0 |
NuCana plc | Sponsored ADR | 67022C106 | 2,382 | 460,672 | SH | | SOLE | | 460,672 | 0 | 0 |
Omega Healthcare Investors, Inc. | Common | 681936100 | 9,175 | 306,433 | SH | | SOLE | | 306,433 | 0 | 0 |
Ovid Therapeutics Inc. | Sponsored ADR | 690469101 | 2,139 | 372,733 | SH | | SOLE | | 372,733 | 0 | 0 |
PerkinElmer, Inc. | Common | 714046109 | 4,831 | 38,494 | SH | | SOLE | | 38,494 | 0 | 0 |
Perrigo Co. plc | Shares | G97822103 | 2,352 | 51,224 | SH | | SOLE | | 51,224 | 0 | 0 |
Pfizer Inc. | Common | 717081103 | 62,235 | 1,695,768 | SH | | SOLE | | 1,695,768 | 0 | 0 |
Physicians Realty Trust | Common | 71943U104 | 8,879 | 495,733 | SH | | SOLE | | 495,733 | 0 | 0 |
Pieris Pharmaceuticals, Inc. | Common | 720795103 | 3,000 | 1,449,269 | SH | | SOLE | | 1,449,269 | 0 | 0 |
PRA Health Sciences, Inc. | Common | 69354M108 | 8,067 | 79,526 | SH | | SOLE | | 79,526 | 0 | 0 |
Quest Diagnostics Inc. | Common | 74834L100 | 12,555 | 109,659 | SH | | SOLE | | 109,659 | 0 | 0 |
Reata Pharmaceuticals, Inc. | Class A | 75615P103 | 7,447 | 76,440 | SH | | SOLE | | 76,440 | 0 | 0 |
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 116,092 | 207,388 | SH | | SOLE | | 207,388 | 0 | 0 |
REGENXBIO Inc. | Common | 75901B107 | 597 | 21,700 | SH | | SOLE | | 21,700 | 0 | 0 |
ResMed Inc. | Common | 761152107 | 16,641 | 97,069 | SH | | SOLE | | 97,069 | 0 | 0 |
Revance Therapeutics, Inc. | Common | 761330109 | 2,158 | 85,840 | SH | | SOLE | | 85,840 | 0 | 0 |
Sabra Health Care REIT, Inc. | Common | 78573L106 | 7,039 | 510,660 | SH | | SOLE | | 510,660 | 0 | 0 |
Sage Therapeutics, Inc. | Common | 78667J108 | 5,880 | 96,211 | SH | | SOLE | | 96,211 | 0 | 0 |
Sanofi | Sponsored ADR | 80105N105 | 19,161 | 381,920 | SH | | SOLE | | 381,920 | 0 | 0 |
Sarepta Therapeutics, Inc. | Common | 803607100 | 28,997 | 206,487 | SH | | SOLE | | 206,487 | 0 | 0 |
Seagen Inc. | Common | 812578102 | 65,987 | 337,204 | SH | | SOLE | | 337,204 | 0 | 0 |
Smith & Nephew plc | Shares | 83175M205 | 3,893 | 99,560 | SH | | SOLE | | 99,560 | 0 | 0 |
Spectrum Pharmaceuticals, Inc. | Common | 84763A108 | 468 | 114,670 | SH | | SOLE | | 114,670 | 0 | 0 |
STERIS plc | Shares | G8473T100 | 22,337 | 126,779 | SH | | SOLE | | 126,779 | 0 | 0 |
Stryker Corp. | Common | 863667101 | 32,887 | 157,830 | SH | | SOLE | | 157,830 | 0 | 0 |
Sutro Biopharma, Inc. | Common | 869367102 | 6,445 | 641,268 | SH | | SOLE | | 641,268 | 0 | 0 |
Syneos Health, Inc. | Class A | 87166B102 | 5,741 | 108,001 | SH | | SOLE | | 108,001 | 0 | 0 |
Takeda Pharmaceutic | Sponsored ADS | 874060205 | 3,749 | 210,146 | SH | | SOLE | | 210,146 | 0 | 0 |
Teleflex Inc. | Common | 879369106 | 5,873 | 17,252 | SH | | SOLE | | 17,252 | 0 | 0 |
Tenet Healthcare Corp. | Common | 88033G407 | 2,371 | 96,736 | SH | | SOLE | | 96,736 | 0 | 0 |
Tetraphase Pharmaceuticals, Inc. | Common | 881CVR013 | 9 | 42,965 | SH | | SOLE | | 42,965 | 0 | 0 |
Teva Pharmaceutical Industries Ltd. | Sponsored ADR | 881624209 | 7,081 | 785,851 | SH | | SOLE | | 785,851 | 0 | 0 |
Theravance Biopharma, Inc. | Common | G8807B106 | 4,413 | 298,470 | SH | | SOLE | | 298,470 | 0 | 0 |
Thermo Fisher Scientific Inc. | Common | 883556102 | 13,008 | 29,461 | SH | | SOLE | | 29,461 | 0 | 0 |
Tricida, Inc. | Common | 89610F101 | 456 | 50,370 | SH | | SOLE | | 50,370 | 0 | 0 |
Trillium Therapeutics Inc. | Common | 89620X506 | 6,367 | 448,049 | SH | | SOLE | | 448,049 | 0 | 0 |
Turning Point Therapeutics, Inc. | Common | 90041T108 | 496 | 5,677 | SH | | SOLE | | 5,677 | 0 | 0 |
Ultragenyx Pharmaceutical Inc. | Common | 90400D108 | 8,012 | 97,480 | SH | | SOLE | | 97,480 | 0 | 0 |
uniQure N.V. | Shares | N90064101 | 2,322 | 63,039 | SH | | SOLE | | 63,039 | 0 | 0 |
United Therapeutics Corp. | Class B | 91307C102 | 6,415 | 63,513 | SH | | SOLE | | 63,513 | 0 | 0 |
Unitedhealth Group Inc. | Common | 91324P102 | 57,907 | 185,735 | SH | | SOLE | | 185,735 | 0 | 0 |
Universal Health Realty Income Trust | Shares | 91359E105 | 642 | 11,258 | SH | | SOLE | | 11,258 | 0 | 0 |
Ventas, Inc. | Common | 92276F100 | 8,732 | 208,108 | SH | | SOLE | | 208,108 | 0 | 0 |
Verona Pharma plc | Sponsored ADR | 925050106 | 2,967 | 475,402 | SH | | SOLE | | 475,402 | 0 | 0 |
Vertex Pharmaceuticals Inc. | Common | 92532F100 | 109,218 | 401,360 | SH | | SOLE | | 401,360 | 0 | 0 |
VYNE Therapeutics Inc. | Common | 92941V100 | 899 | 541,584 | SH | | SOLE | | 541,584 | 0 | 0 |
Waters Corp. | Common | 941848103 | 21,429 | 109,510 | SH | | SOLE | | 109,510 | 0 | 0 |
Welltower Inc. | Common | 95040Q104 | 11,188 | 203,083 | SH | | SOLE | | 203,083 | 0 | 0 |
Xencor, Inc. | Common | 98401F105 | 5,750 | 148,231 | SH | | SOLE | | 148,231 | 0 | 0 |
Y-mAbs Therapeutics, Inc. | Common | 984241109 | 2,939 | 76,548 | SH | | SOLE | | 76,548 | 0 | 0 |
Zai Lab Ltd. | ADR | 98887Q104 | 3,121 | 37,523 | SH | | SOLE | | 37,523 | 0 | 0 |
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 26,130 | 191,937 | SH | | SOLE | | 191,937 | 0 | 0 |
Zoetis Inc. | Class A | 98978V103 | 9,347 | 56,521 | SH | | SOLE | | 56,521 | 0 | 0 |
Zogenix, Inc. | Common | 98978L204 | 5,978 | 333,402 | SH | | SOLE | | 333,402 | 0 | 0 |
Zymeworks Inc. | Common | 98985W102 | 2,606 | 55,938 | SH | | SOLE | | 55,938 | 0 | 0 |